A multicentre study of amphotericin B treatment for histoplasmosis: assessing mortality rates and adverse events.
Sekiguchi WK, de Oliveira VF, Cavassin FB, Taborda M, Gonçalves Kono Magri AS, da Cruz ICLV, Vidal JE, Falci DR, Silva de Miranda Godoy C, de Bastos Ascenço Soares R, de Oliveira CS, Mendes AVA, Breda GL, Rego CM, Félix MA, Katopodis PP, da Silva do Ó JR, Abrão MPL, Baú-Carneiro JL, Pereira TTT, Queiroz-Telles F, Mihailenko Chaves Magri M.
Sekiguchi WK, et al. Among authors: de oliveira vf.
J Antimicrob Chemother. 2024 Oct 1;79(10):2598-2606. doi: 10.1093/jac/dkae264.
J Antimicrob Chemother. 2024.
PMID: 39074040